市場調查報告書
商品編碼
1535238
ERCP及PTC設備市場:各市場區隔規模,佔有率,法律規章,償付,手術,2033年為止的預測ERCP and PTC Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
內視鏡逆行性胰膽管攝影 (ERCP) 是一種針對肝臟和胰臟引流管(包括膽管、膽囊和胰管)的內視鏡和放射學聯合手術。當膽管嚴重狹窄且難以透過內視鏡觀察時,或當先前的手術使內視鏡進入變得困難時,經皮肝穿刺膽管造影(PTC)對於進入膽管非常有用。
ERCP 和 PTC 通常用於治療阻塞性黃疸和控制膽漏(無論是良性還是惡性)。它也用於預防胰臟炎以及排出膽囊和胰液。這些裝置主要透過兩種方式放置:內視鏡逆行性胰膽管攝影(ERCP)和經皮肝穿刺膽管攝影(PTC)。
本報告提供全球ERCP及PTC設備市場相關資料詳細考察,提供市場上競爭情形,SWOT分析,到2033年為止的市場預測,地區,各國的趨勢等資訊。
ERCP and PTC Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a combined endoscopic and radiologic procedure for the ducts draining the liver and pancreas which includes bile ducts, gallbladder, and pancreatic ducts. Percutaneous Transhepatic Cholangiography (PTC) is useful in accessing the biliary tree when a high-grade stricture precludes endoscopic visualization or when prior surgery makes endoscopic access difficult.
ERCP and PTC devices are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These devices are also used for preventing pancreatitis and to drain the gallbladder and pancreatic fluids. These devices are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed ERCP and PTC Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, ConMed Corp, Cook Medical Inc, Olympus Corp, Merit Medical Systems Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -